GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Cyclically Adjusted Revenue per Share

HealthEquity (HealthEquity) Cyclically Adjusted Revenue per Share : $7.24 (As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

HealthEquity's adjusted revenue per share for the three months ended in Jan. 2024 was $2.992. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $7.24 for the trailing ten years ended in Jan. 2024.

During the past 12 months, HealthEquity's average Cyclically Adjusted Revenue Growth Rate was 19.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-26), HealthEquity's current stock price is $79.27. HealthEquity's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was $7.24. HealthEquity's Cyclically Adjusted PS Ratio of today is 10.95.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of HealthEquity was 12.87. The lowest was 8.54. And the median was 10.28.


HealthEquity Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for HealthEquity's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Cyclically Adjusted Revenue per Share Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.08 7.24

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.08 6.41 6.69 6.98 7.24

Competitive Comparison of HealthEquity's Cyclically Adjusted Revenue per Share

For the Health Information Services subindustry, HealthEquity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HealthEquity's Cyclically Adjusted PS Ratio falls into.



HealthEquity Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HealthEquity's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=2.992/130.1244*130.1244
=2.992

Current CPI (Jan. 2024) = 130.1244.

HealthEquity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201404 0.408 100.023 0.531
201407 0.501 100.520 0.649
201410 0.380 100.176 0.494
201501 0.434 98.604 0.573
201504 0.517 99.824 0.674
201507 0.517 100.691 0.668
201510 0.516 100.346 0.669
201601 0.604 99.957 0.786
201604 0.741 100.947 0.955
201607 0.741 101.524 0.950
201610 0.722 101.988 0.921
201701 0.774 102.456 0.983
201704 0.903 103.167 1.139
201707 0.921 103.278 1.160
201710 0.918 104.070 1.148
201801 0.970 104.578 1.207
201804 1.115 105.708 1.373
201807 1.121 106.324 1.372
201810 1.103 106.695 1.345
201901 1.211 106.200 1.484
201904 1.362 107.818 1.644
201907 1.321 108.250 1.588
201910 2.228 108.577 2.670
202001 2.780 108.841 3.324
202004 2.628 108.173 3.161
202007 2.433 109.318 2.896
202010 2.304 109.861 2.729
202101 2.390 110.364 2.818
202104 2.253 112.673 2.602
202107 2.265 115.183 2.559
202110 2.154 116.696 2.402
202201 2.428 118.619 2.663
202204 2.448 121.978 2.611
202207 2.441 125.002 2.541
202210 2.555 125.734 2.644
202301 2.760 126.223 2.845
202304 2.839 127.992 2.886
202307 2.821 128.974 2.846
202310 2.861 129.810 2.868
202401 2.992 130.124 2.992

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


HealthEquity  (NAS:HQY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

HealthEquity's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=79.27/7.24
=10.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of HealthEquity was 12.87. The lowest was 8.54. And the median was 10.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


HealthEquity Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of HealthEquity's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (HealthEquity) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg officer: Chief Operating Officer 13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan director 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596